Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
32 publications from 2016
Clarke L, Smyth P, Blackshields G, Jeffers M, Quinn F, O'Leary J, Vandenberghe E, Sheils O, Flavin R, MicroRNA expression in enteropathy associated T-cell lymphoma type 1 , 2016, 469 , (SUPPL 1 ), SPRINGER ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES , 2016, ppS35 - S35
D.J. McHugh, P. Gou, J. Quinn, P. Thornton, B. Bird, S. Sukor, A. Fortune, K. Perera, L. Bacon, E. Vandenberghe, R. Flavin, C. Grant, Prevalence, clinico-pathological features and outcomes of 'double-hit' high-grade B-cell non-Hodgkins lymphoma (NHL): a single institution experience, Annals of Oncology, 27, (Suppl 6), 2016, ppVI315
Blanaid Mee, Eoin Gaffney, Sarah McGarrigle, Sharon A Glynn, Elisabeth M Connolly, Paul H McCormick, Delia Flannery, Katrina O'Connor, Margaret Lawson, Lisa Ryan, Timothy Nugent, Ronan Ward, Francis J Sullivan, Joanna Fay, Tony O'Grady, Elaine Kay, Joe Eustace, Louise Burke, Stephen Finn, Richard Flavin, Can a biobank network and supporting infrastructure enhance Ireland's ability to attract pharmaceutical research and development and clinical trial opportunities? A pilot survey. , Journal of Biorepository Science for Applied Medicine. , 4, 2016, p1 - 8
Cooney A, Ffrench B, Spillane CD, Ruttle C, Gleeson N, O'Riain C, Flavin R, Gallagher MF, Martin C, Sheils O, O'Toole S, O'Leary J, Digital Multi-Colour CTC Detection, Laboratory Investigation, 96, (A511), A512, 2016
Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Transdisciplinary Prostate Cancer Partnership (ToPCaP), Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort., Carcinogenesis, 2016
Langabeer SE, Haslam K, O'Brien D, Kelly J, Andrews C, Ryan C, Flavin R, Hayden PJ, Bacon CL, Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia., Case reports in hematology, 2016
Spillane C, Ffrench B, Cooney A, Ruttle C, Bogdanska A, Gleeson N, Abu Saadeh F, Waseem K, O'Riain C, Flavin R, A NOVEL DIGITIAL PATHOLOGY APPROACH TO DEFINITIVELY IDENTIFY OVARIAN CANCER CTCS , 2016, 26 , LIPPINCOTT WILLIAMS & WILKINS TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, 2016, pp796 - 796
O'Connor M, Waller J, Gallagher P, Martin CM, JO'Leary J, D'Arcy T, Prendiville W, Flannelly G, Sharp L., Exploring women's sensory experiences of undergoing colposcopy and related procedures: implications for preparatory sensory information provision., Journal of psychosomatic obstetrics and gynaecology, 37, (4), 2016, p137-146
O'Connor M, Gallagher P, Waller J, Martin CM, O'Leary JJ, Sharp L, Irish Cervical Screening Research Consortium (CERVIVA)., Adverse psychological outcomes following colposcopy and related procedures: a systematic review., BJOG : an international journal of obstetrics and gynaecology, 123, (1), 2016, p24-38
Tonry Claire L, Leacy Emma, Raso Cinzia, Finn Stephen P, Armstrong John, Pennington Stephen R, The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer , Diagnostics (Basel, Switzerland) , 6 , (3 ), 2016
Markt Sarah C, Nuttall Elizabeth, Turman Constance, Sinnott Jennifer, Rimm Eric B, Ecsedy Ethan, Unger Robert H, Fall Katja, Finn Stephen, Jensen Majken K, Rider Jennifer R, Kraft Peter, Mucci Lorelei A, Sniffing out significant "Pee values": genome wide association study of asparagus anosmia , BMJ (Clinical research ed.) , 355 , 2016, pi6071 -
Hayes, B.D., Brady, L., Pollak, M., Finn, S.P., Exercise and prostate cancer: Evidence and proposed mechanisms for disease modification, Cancer Epidemiology Biomarkers and Prevention, 25, (9), 2016, p1281-1288
Ahearn, T.U., Tchrakian, N., Wilson, K.M., Lis, R., Nuttall, E., Sesso, H.D., Loda, M., Giovannucci, E., Mucci, L.A., Finn, S., Shui, I.M., Calcium-sensing receptor tumor expression and lethal prostate cancer progression, Journal of Clinical Endocrinology and Metabolism, 101, (6), 2016, p2520-2527
Heavey S, Cuffe S, Finn S, Young V, Ryan R, Nicholson S, Leonard N, McVeigh N, Barr M, O'Byrne K, Gately K, In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC, Oncotarget, 7, (48), 2016, p79526 - 79543
Hallinan N, Finn S, Cuffe S, Rafee S, O'Byrne K, Gately K, Targeting the fibroblast growth factor receptor family in cancer, Cancer Treatment Reviews, 46, 2016, p51 - 62
McGovern B, Quinn F, Andrews C, Jeffers M, Bacon CL, Bird B, Crotty G, Vandenberghe E, Flavin R, NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia., 2016
Ryan C, Ged Y, Quinn F, Walker J, Kennedy J, Gillham C, Pittaluga S, McDermott R, Vandenberghe E, Grant C, Flavin R, Classical Hodgkin Lymphoma Arising Adjacent to a Breast Implant., 2016
Murray C, Quinn F, Illyes G, Walker J, Castriciano G, O'Sullivan P, Grant C, Vandenberghe E, Bird B, Flavin R, Composite Blastoid Variant of Mantle Cell Lymphoma and Classical Hodgkin Lymphoma., 2016
O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA., Urinary Soluble CD163 in Active Renal Vasculitis., Journal of the American Society of Nephrology, 27, (9), 2016, p2906 - 2916
White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM. , Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study. , Cytopathology, 27, (4), 2016, p269 - 276
O'Connor M, O'Leary E, Waller J, Gallagher P, D'Arcy T, Flannelly G, Martin C.M, McRae J, Prendiville W, Ruttle C, White C, Pilkington L, O'Leary J.J, Sharp L, Trends in, and predictors of, anxiety and specific worries following colposcopy: A 12-month longitudinal study, Psycho-Oncology, 25, (5), 2016, p597 - 604
Gray, S.G., Cuffe, S., Finn, S.P., PD-L1 as a companion biomarker for immune checkpoint inhibitors in NSCLC: Should RNA ISH (RISH) be considered?, Journal of Thoracic Oncology, 11, (11), 2016, e142-e144
Joerger, M., Finn, S.P., Cuffe, S., Byrne, A.T., Gray, S.G., The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?, Expert Opinion on Therapeutic Targets, 20, (11), 2016, 1339-1356
Aherne, S.T., Smyth, P., Freeley, M., Smith, L., Spillane, C., O'Leary, J., Sheils, O., Altered expression of MIR-222 and MIR-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression, International Journal of Molecular Medicine, 38, (2), 2016, p433-445
Emma R Dorris, Gordon Blackshields, Gary Sommerville, Mohsen Alhashemi, Andrew Dias, Victoria McEneaney, Paul Smyth, John J O'Leary, Orla Sheils, Pluripotency markers are differentially induced by MEK inhibition in thyroid and melanoma BRAFV600E cell lines, Cancer biology & therapy, 17, (5), 2016, p526 - 542
Cregan S, McDonagh L, Gao Y, Barr MP, O'Byrne KJ, Finn SP, Cuffe S, Gray SG, KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma., International journal of oncology, 48, (3), 2016, p1290-6
MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O'Byrne KJ, Barr MP, Lung cancer stem cells: The root of resistance., Cancer letters, 372, (2), 2016, p147-56
Leon, G., MacDonagh, L., Finn, S.P., Cuffe, S., Barr, M.P., Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways, Pharmacology and Therapeutics, 158, 2016, p71 - 90
Staunton, L., Tonry, C., Lis, R., Finn, S., O'Leary, J., Loda, M., Bowden, M., Pennington, S.R., Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LC-MS-A technical report, EuPA Open Proteomics, 10, 2016, p19-23
Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA, Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression., 2016
Cregan S, McDonagh L, Gao Y, Barr MP, O'Byrne KJ, Finn SP, Cuffe S, Gray SG, KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma., International Journal of Oncology, 48, (3), 2016, p1290-1296
MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O'Byrne KJ, Barr MP, Lung cancer stem cells: The root of resistance., 2016